Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L. reuteri for Prevention of Glucocorticoid-Induced Bone Loss
NCT04767711Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- May 2022
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Sahlgrenska University Hospital. Primary endpoints: Change in serum osteocalcin, Change in serum PINP and 1 more. Started May 2022; status: completed.
Beyond the preview
Go deeper on NCT04767711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04767711.